Treace Medical Concepts TMCI
NASDAQ TMCI
$4.46 -0.10 (-2.19%)
As of: Aug 20, 2026 · 3:59 PM EDT

Treace Medical Concepts (TMCI) Net Margin Growth (3y) (2023 - 2026)

Treace Medical Concepts (TMCI) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -641.00
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 459.00
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -108.00
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 941.00
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -1,024.00
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 574.00
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 216.00
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 647.00
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 300.00
10 Treace Medical Concepts 290.12 Mn 244.50 Mn 35.61 Mn -595.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,123.00
Mar 31, 2026 -1,198.00
Dec 31, 2025 -227.00
Sep 30, 2025 409.00
Jun 30, 2025 2,054.00
Mar 31, 2025 57.00
Dec 31, 2024 1,852.00
Sep 30, 2024 -443.00
Jun 30, 2024 -2,316.00
Mar 31, 2024 -2,284.00
Dec 31, 2023 -2,023.00
Sep 30, 2023 -2,331.00
Jun 30, 2023 -193.00
Mar 31, 2023 -1,651.00